Exploring the sheep (Ovis aries) immunoglobulin repertoire by next generation sequencing.
CDR3 composition
CDR3 diversity
Gene usage
Immunoglobulin (IGH/IGK/IGL) repertoire analysis
Next-generation sequencing
Ovis aries/Sheep
Journal
Molecular immunology
ISSN: 1872-9142
Titre abrégé: Mol Immunol
Pays: England
ID NLM: 7905289
Informations de publication
Date de publication:
04 2023
04 2023
Historique:
received:
15
12
2022
revised:
10
02
2023
accepted:
23
02
2023
medline:
31
3
2023
pubmed:
4
3
2023
entrez:
3
3
2023
Statut:
ppublish
Résumé
Next-generation sequencing (NGS) has revolutionized the way we determine the antibody repertoires encoded by B cells in the blood or lymphoid organs and transformed our understanding of adaptive immune responses in many species. Sheep (Ovis aries) have been widely used as a host for therapeutic antibody production since the early 1980s, however, little is known about their immune repertoires or immunological processes affecting the antibody generation. The objective of this study was to employ NGS for a comprehensive analysis of immunoglobulin heavy and light chain repertoires in four healthy sheep. We obtained > 90 % complete antibody sequences and nearly 130,000, 48,000 and 218,000 unique CDR3 reads for the heavy chain (IGH), kappa chain (IGK), and lambda chain (IGL) loci, respectively. Consistent with other species, we observed biased usage of germline variable (V), diversity (D) and joining (J) genes in the heavy and kappa loci, but not in the lambda loci. Moreover, the enormous diversity of CDR3 sequences was observed through sequence clustering and convergent recombination. These data will build a foundation for future studies investigating immune repertoires in health and disease as well as contribute to further refinement of ovine-derived therapeutic antibody drugs.
Identifiants
pubmed: 36867981
pii: S0161-5890(23)00030-5
doi: 10.1016/j.molimm.2023.02.008
pii:
doi:
Types de publication
Journal Article
Langues
eng
Sous-ensembles de citation
IM
Pagination
20-30Informations de copyright
Copyright © 2023 The Authors. Published by Elsevier Ltd.. All rights reserved.
Déclaration de conflit d'intérêts
Declaration of Interests The authors declare the following competing financial interest(s): M.P., T.N.V.D., V.L., L.W., and T.L.B. are employed by Rapid Novor Inc.; B.M. is co-owner of Rapid Novor Inc.